Tyson Foods Inc., a leading global meat processor, has announced it will remove the "No Antibiotics Ever" label from select chicken products, reintroducing antibiotics not significant to human treatment. This policy shift has raised eyebrows, given the growing concern about antibiotic resistance fueled by food production practices.
Tyson Foods ditched the drug for infections eight years ago, and since then, the “no antibiotics ever” has been emblazoned on its chicken products’ label packaging. Then again, only some of the chicken items are set to lose the mentioned phrase on the label.
According to CNN Business, the Springdale, Arkansas-based food processing company will start using antibiotics in its chicken production and said that this is the type that is not important to the treatment of humans. In any case, the use of antibiotics in food production or processing has been heavily scrutinized in recent years because some bacteria have become resistant to medicines and treatment due to repeated exposure to antibiotics.
“At Tyson Foods, we base our decisions on sound science and an evolving understanding of the best practices impacting our customers, consumers, and the animals in our care,” the spokesperson of Tyson Foods said in a statement.
The company said that some of its chicken would start deleting the “no antibiotics important to human medicine” on the label by the end of this year. Tyson Foods ascertained it would only apply antibiotics that are up to the standard and recognized by the USDA and the World Health Organization (WHO).
It was in 2015 when the company announced its decision to eliminate the antibiotics in its chicken wings, breast, and chicken nuggets. At the time, the company said it was working to get rid of the drug as it was worried about the increase in antibiotic-resistant bacterial infections in humans. It added that it would like to play its part in helping reduce the human consumption of antibiotics.
Meanwhile, The Wall Street Journal was the first to report on Tyson Foods’ decision to resume its use of non-medically important antibiotics in some of its chicken production. “Based on current science, Tyson brand products are transitioning to No Antibiotics Important to Human Medicine (NAIHM), which is expected to be complete by the end of the calendar year,” the company’s representative stated.


UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
US Dollar Dips as Iran Rejects Ceasefire Amid Rising Middle East Tensions
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Gold Surges Near 3-Week High as Trump-Iran Ceasefire Eases Geopolitical Tensions
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
U.S.-Iran Ceasefire: Fragile Truce Raises Hopes for Strait of Hormuz Peace Deal
Energy Prices and Dollar Climb as U.S.-Iran Conflict Grips Global Markets
First Western Ship Transits Strait of Hormuz Since Iran War Began
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push 



